NeuroScience Inc. - Detailed results
 

-
373 280th Street
Osceola, WI 54020
Tel. 715-294-2144
Fax. 715-294-3921

Frank C

Frank


DTI# 121678


Last updated on 2005-10-21

Sex: Male
Date of birth: 1944-02-13
Phone:
Provider: Elias, Katherine
Collection Date: 2005-09-20
Date Received: 2005-09-23
Reporting Date: 2005-10-12
Date Logged: 2005-09-23

Measured value
Result
Time
Optimal Range Therapeutic Range Observed Range
Epinephrine-Urine
(g/gCr)
2.1
10:30 AM
Day: 8-12
Night: 1-2
Day: 8-13
Night: 1-2
Day: 1-15
Night: <2
Norepinephrine-Urine
(g/gCr)
50.5
10:30 AM
Day: 30-55
Night: 25-35
Day: 30-75
Night: 25-35
Day: 15-106
Night: 15-40
Dopamine-Urine
(g/gCr)
75.9
10:30 AM
Day: 125-175
Night: 80-120
Day: 200-350
Night: 125-250
Day: 50-350
Night: 45-250
Serotonin-Urine
(g/gCr)
115.3
10:30 AM
Day: 175-225
Night: 100-175
Day: 250-950
Night: 120-250
Day: 40-275
Night: 25-250
GABA-Urine
(umol/gCr)
7.1
10:30 AM
Day: 1.5-4.0
Night: 1-3
Day: 10-15
Night: 5-8
Day: 1.5-35
Night: 1.5-20
Creatinine-Urine
(mg/dL)
248.4
10:30 AM
N/A
N/A
N/A
Measured value
Result
Time
Optimal Range Therapeutic Range Observed Range

COMMENTS:
Test results and recommendations made by NeuroScience for treatment are only guidelines and the final treatment protocol and diagnosis should be interpreted by the healthcare provider. This information is intended for health care providers only. For more information, please visit our website at www.neuroscienceinc.com.

Epinephrine is very low. Norepinephrine is normal. Dopamine is low. Serotonin is low. GABA is elevated.

.Recommend adding to present regimen Adrecor( 1-3 capsule) 30 minutes before morning and afternoon meals. If using powder(1/2 to 1 scoop) 30 minutes before morning meal

.Phase 1: Weeks 1&2 (or more if needed)
TravaCor (2-3 capsules) twice a day (30 minutes prior to morning and evening meals)
EndoPlus (2 sprays) 3-5 times daily

Phase 2: Week 3 and on
ExcitaCor (1 capsule) once a day (30 minutes prior to morning meal)
TravaCor (2-3 capsules) twice a day (30 minutes prior to
evening meal and bedtime)
EndoPlus (2 sprays) 3-5 times per day

Phase 3:
ExcitaCor (1 capsule) once a day (30 minutes prior to morning meal)
TravaCor (1 capsule) twice a day (30 minutes prior to evening meal and bedtime)

Retest in 4-6 weeks after beginning therapy or sooner if needed

Phase 1 is designed to support inhibitory neurotransmitter levels such as GABA, serotonin, and taurine. During this phase, anxiousness, depressive, or sleep related symptoms can be expected to improve. Initial nausea, vomiting, or GI upset may occur but is only a temporary response and can be addressed through adjusting dosage or buffering supplementation with food.

Phase 2 generally continues until neurotransmitter levels have been optimized and symptom resolution is achieved, and usually takes a minimum of 3 months. This is followed by a transition into phase 3 of treatment.

Phase 3 is important for maintaining adequate neurotransmitter levels. Without continued supplemental support, transmitter levels will revert to baseline values. As a result, clinical symptoms may reappear.

All supplements recommended at mealtimes should be taken 1/2 hour prior to eating.

TravaCor is a combination of ingredients designed to raise serotonin and support GABA. It also contains theanine to reduce neurotransmitter excretion.

ExcitaCor contains Mucuna for catecholamine support, as well as histidine, a precursor to histamine. Histamine affects enzymes that influence neurotransmission. Also included is Rhodiola, a nervous system stimulator.

EndoPlus (theanine & 5-HTP) is a liposomal formula that reduces excitatory neurotransmitter activity and supports serotonin. Theanine is used symptomatically as an anti-anxiety and anti-hyperactivity amino acid.


Note: These comments are not intended to diagnose, treat, or cure a disease. Final therapeutic decisions are the responsibility of the clinician.